Reaction
Product After Taste reporting signals
As of the last recalculation, Product After Taste appears in 925 FAERS reports alongside 19 co-occurring drug terms. The strongest observed disproportionality signal is LIFITEGRAST (PRR 109.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Lifitegrast | 73 | 109.1 | 109.6 |
| Icosapent Ethyl | 32 | 87.6 | 87.9 |
| Budesonide, Glycopyrrolate, And Formoterol Fumarate | 22 | 48.5 | 48.6 |
| Rimegepant Sulfate | 13 | 23.4 | 23.4 |
| Levodopa | 10 | 18.8 | 18.8 |
| Instalax Polyethylene Glycol 3350 | 9 | 16.5 | 16.5 |
| Polyethylene Glycol 400 | 9 | 16.1 | 16.1 |
| Carboxymethylcellulose Sodium | 6 | 14.5 | 14.5 |
| Nirmatrelvir And Ritonavir | 29 | 12.4 | 12.4 |
| Nicotine Polacrilex | 19 | 11.4 | 11.4 |
| Nicotine | 20 | 11.4 | 11.4 |
| Treprostinil | 57 | 10.8 | 10.8 |
| Abaloparatide | 13 | 10.1 | 10.1 |
| Oral Semaglutide | 31 | 9.8 | 9.8 |
| Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate | 16 | 8.8 | 8.8 |
| Vibegron | 3 | 8.4 | 8.4 |
| Tirzepatide | 33 | 4.7 | 4.7 |
| Pirfenidone | 7 | 3.9 | 3.9 |
| Voxelotor | 3 | 3.0 | 3.0 |